Your financial prep guide for AAD Annual Meeting 2027
Dermatology has some of the highest revenue potential in outpatient care and some of the widest variance in profitability. Know where you stand before you head to San Francisco. Sorso is not an exhibitor, sponsor, or speaker at this event — this is an independent prep guide for dermatology practice owners.
Why this matters for your bottom line
Dermatology practices with an optimized medical-cosmetic service mix typically run materially healthier EBITDA margins than pure medical practices. Understanding your mix ratio and the margin contribution of each side is essential.
PE-backed dermatology groups are consolidating aggressively. Independent practices need to understand their valuation multiples and what drives premium valuations, whether they plan to sell or compete.
APP (NP/PA) supervision models vary dramatically in profitability. Practices with well-structured APP programs can generate meaningfully more revenue per supervising physician than those without.
New biologic and aesthetic treatments create both revenue opportunities and inventory cost risks. The cash flow impact of stocking expensive biologics requires careful financial planning.
What to look for
Medical-cosmetic integration financial models and optimal revenue mix ratios
APP supervision economics: revenue per APP, supervision ratios, and margin impact
Practice valuation and PE transaction trends for independent dermatology practices
Biologic and specialty drug inventory management and financial impact
Ancillary revenue opportunities: pathology, phototherapy, cosmetic procedures
Financial prep checklist
Review these before you go.
Break down your revenue by medical vs. cosmetic services with margin for each
Calculate revenue per provider per day segmented by physicians, NPs, and PAs
Know your pathology revenue and whether you are capturing all billable specimens
Pull your cosmetic conversion rate: consults that result in booked procedures
Review your inventory carrying costs, especially for biologics and cosmetic injectables
Benchmark your total overhead against AAD survey data for your practice size
From our CFO
AAD is a clinical powerhouse, but the financial opportunity in dermatology comes from optimizing the medical-cosmetic mix and APP leverage. The practices with the best margins are not necessarily the busiest. They are the ones that know exactly which services contribute the most profit and allocate their providers and marketing spend accordingly.
Get a financial checkup before AAD Annual Meeting 2027
Take the 4-minute financial assessment. Know your numbers before you attend, so you can ask better questions and make better decisions.